FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4286202963> ?p ?o ?g. }

• W4286202963 endingPage "191" @default.
• W4286202963 startingPage "185" @default.
• W4286202963 abstract "Cell-based immunotherapy is categorized as a regenerative therapy under the Regenerative Medicine Safety Act in Japan. Natural killer (NK) cell-based immunotherapy is considered a promising strategy for treating cancer, including glioblastoma (GBM). We previously reported an expansion method for highly purified human peripheral blood-derived NK cells using a cytokine cocktail. Here, we aimed to establish a more efficient NK cell expansion method as compared to our previously reported method.T cell-depleted human peripheral blood mononuclear cells (PBMCs) were isolated from three healthy volunteers. The depleted PBMCs were cultured in the presence of recombinant human interleukin (rhIL)-18 and high-dose rhIL-2 in anti-NKp46 and/or anti-CD16 antibody immobilization settings. After 14 days of expansion, the purity and expansion ratio of CD3-CD56+ NK cells were determined. The cytotoxicity-mediated growth inhibition of T98G cells (an NK activity-sensitive GBM cell line) was evaluated using a non-labeling, impedance-based real-time cell analyzer.Anti-NKp46 stimulation increased the NK cell purity and expansion ratio as compared to the non-antibody-stimulated population. Anti-CD16 stimulation weakly enhanced the NK cell expansion ratio of the non-antibody-stimulated population and enhanced the NK cell purity and expansion ratio of anti-NKp46-stimulated populations. All NK cell-containing populations tested distinctly inhibited T98G cell growth. These effects tended to be enhanced in an NK cell purity-dependent manner. In some cases, anti-CD16 stimulation decreased growth inhibition of T98G cell compared to other conditions despite the comparable NK cell purity.We established a robust large-scale feeder-free expansion system for highly purified human NK cells using a defined cytokine cocktail and anti-NK cell activating receptor antibodies. The expansion system could be feasible for autologous or allogeneic NK cell-based immunotherapy of GBM. Moreover, it is easily controlled under Japanese law on regenerative medicine." @default.
• W4286202963 created "2022-07-21" @default.
• W4286202963 creator A5002163440 @default.
• W4286202963 creator A5005857743 @default.
• W4286202963 creator A5017172069 @default.
• W4286202963 creator A5038389153 @default.
• W4286202963 creator A5048922044 @default.
• W4286202963 creator A5060268134 @default.
• W4286202963 creator A5060916666 @default.
• W4286202963 creator A5063373940 @default.
• W4286202963 creator A5078888657 @default.
• W4286202963 creator A5080351529 @default.
• W4286202963 creator A5087179801 @default.
• W4286202963 date "2022-12-01" @default.
• W4286202963 modified "2023-10-06" @default.
• W4286202963 title "Establishment of an efficient ex vivo expansion strategy for human natural killer cells stimulated by defined cytokine cocktail and antibodies against natural killer cell activating receptors" @default.
• W4286202963 cites W1828402880 @default.
• W4286202963 cites W1987562611 @default.
• W4286202963 cites W2019804037 @default.
• W4286202963 cites W2020646453 @default.
• W4286202963 cites W2023082289 @default.
• W4286202963 cites W2057776379 @default.
• W4286202963 cites W2060007562 @default.
• W4286202963 cites W2083913631 @default.
• W4286202963 cites W2092166052 @default.
• W4286202963 cites W2095393557 @default.
• W4286202963 cites W2096287682 @default.
• W4286202963 cites W2099019634 @default.
• W4286202963 cites W2099570622 @default.
• W4286202963 cites W2101156161 @default.
• W4286202963 cites W2112101851 @default.
• W4286202963 cites W2118796952 @default.
• W4286202963 cites W2129278872 @default.
• W4286202963 cites W2147787458 @default.
• W4286202963 cites W2165813814 @default.
• W4286202963 cites W2171709048 @default.
• W4286202963 cites W2272769504 @default.
• W4286202963 cites W2366536035 @default.
• W4286202963 cites W2395532360 @default.
• W4286202963 cites W2414201735 @default.
• W4286202963 cites W2565724550 @default.
• W4286202963 cites W2738678436 @default.
• W4286202963 cites W2753771069 @default.
• W4286202963 cites W2787621143 @default.
• W4286202963 cites W2921252083 @default.
• W4286202963 cites W2994704114 @default.
• W4286202963 cites W2995575626 @default.
• W4286202963 cites W2998493318 @default.
• W4286202963 cites W3003318458 @default.
• W4286202963 cites W3006483160 @default.
• W4286202963 cites W3017329354 @default.
• W4286202963 cites W3087526274 @default.
• W4286202963 cites W3093796335 @default.
• W4286202963 cites W3112854618 @default.
• W4286202963 cites W3119901427 @default.
• W4286202963 cites W3120414804 @default.
• W4286202963 cites W3122724341 @default.
• W4286202963 cites W3148897605 @default.
• W4286202963 cites W3199990456 @default.
• W4286202963 cites W3200157938 @default.
• W4286202963 cites W3203555041 @default.
• W4286202963 cites W4207058776 @default.
• W4286202963 doi "https://doi.org/10.1016/j.reth.2022.07.001" @default.
• W4286202963 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35919498" @default.
• W4286202963 hasPublicationYear "2022" @default.
• W4286202963 type Work @default.
• W4286202963 citedByCount "8" @default.
• W4286202963 countsByYear W42862029632023 @default.
• W4286202963 crossrefType "journal-article" @default.
• W4286202963 hasAuthorship W4286202963A5002163440 @default.
• W4286202963 hasAuthorship W4286202963A5005857743 @default.
• W4286202963 hasAuthorship W4286202963A5017172069 @default.
• W4286202963 hasAuthorship W4286202963A5038389153 @default.
• W4286202963 hasAuthorship W4286202963A5048922044 @default.
• W4286202963 hasAuthorship W4286202963A5060268134 @default.
• W4286202963 hasAuthorship W4286202963A5060916666 @default.
• W4286202963 hasAuthorship W4286202963A5063373940 @default.
• W4286202963 hasAuthorship W4286202963A5078888657 @default.
• W4286202963 hasAuthorship W4286202963A5080351529 @default.
• W4286202963 hasAuthorship W4286202963A5087179801 @default.
• W4286202963 hasBestOaLocation W42862029631 @default.
• W4286202963 hasConcept C114684123 @default.
• W4286202963 hasConcept C129374314 @default.
• W4286202963 hasConcept C137061746 @default.
• W4286202963 hasConcept C1491633281 @default.
• W4286202963 hasConcept C154317977 @default.
• W4286202963 hasConcept C159654299 @default.
• W4286202963 hasConcept C167672396 @default.
• W4286202963 hasConcept C202751555 @default.
• W4286202963 hasConcept C203014093 @default.
• W4286202963 hasConcept C2776090121 @default.
• W4286202963 hasConcept C2777701055 @default.
• W4286202963 hasConcept C2778102761 @default.
• W4286202963 hasConcept C2778690821 @default.
• W4286202963 hasConcept C2781462264 @default.
• W4286202963 hasConcept C28651165 @default.
• W4286202963 hasConcept C2908647359 @default.
• W4286202963 hasConcept C55493867 @default.

• next